Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma

Genes Chromosomes Cancer. 2023 Mar;62(3):171-175. doi: 10.1002/gcc.23105. Epub 2022 Dec 7.

Abstract

HEY1-NCOA2 fusion is most described in mesenchymal chondrosarcoma. This is the first case report of a primary renal spindle cell neoplasm of uncertain malignant potential with a HEY1::NCOA2 fusion identified by Fusionplex RNA-sequencing that is histologically distinct from mesenchymal chondrosarcoma. The neoplasm was identified in a 33-year-old woman without significant past medical history who underwent partial nephrectomy for an incidentally discovered renal mass. The histologic features of the mass included spindle cells with variable cellularity and monotonous bland cytology forming vague fascicles and storiform architecture within a myxoedematous and collagenous stroma with areas of calcification. The morphologic and immunophenotypic features were not specific for any entity but were most similar to low-grade fibromyxoid sarcoma. To date, the patient has not had recurrence, and the malignant potential of the neoplasm is uncertain.

Keywords: HEY1; NCOA2; kidney sarcoma; mesenchymal chondrosarcoma; renal fusion sarcoma; renal spindle cell neoplasm.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Bone Neoplasms* / genetics
  • Bone Neoplasms* / pathology
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Chondrosarcoma, Mesenchymal* / genetics
  • Chondrosarcoma, Mesenchymal* / pathology
  • Chondrosarcoma, Mesenchymal* / surgery
  • Female
  • Humans
  • Nephrectomy
  • Nuclear Receptor Coactivator 2 / genetics

Substances

  • NCOA2 protein, human
  • Nuclear Receptor Coactivator 2
  • HEY1 protein, human
  • Cell Cycle Proteins
  • Basic Helix-Loop-Helix Transcription Factors